Tonix Pharmaceuticals appoints Jim Hunter to its Board, enhancing commercial strategy ahead of TNX-102 SL's potential fibromyalgia launch. Tonix Pharmaceuticals Holding Corp. announced the appointment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback